Status:
UNKNOWN
Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program
Lead Sponsor:
Competence Centre on Health Technologies
Collaborating Sponsors:
Universidad de Granada
Conditions:
Female Infertility
Eligibility:
FEMALE
18-51 years
Phase:
EARLY_PHASE1
Brief Summary
105 infertile women are enrolled in the randomized controlled trial: 70 women with a history of RIF with donated oocytes and 35 infertile women undergoing the first oocyte donation attempt. Women rece...
Detailed Description
This study includes in total 105 infertile couples treated by assisted reproduction with oocyte donation. Seventy couples that have experienced at least two previous failures with this approach at our...
Eligibility Criteria
Inclusion
- Inclusion Criteria for oocyte recipients:
- age below 51 years
- 2 or more previous implantation failures in oocyte donation program
- voluntary participation
- Inclusion Criteria for oocyte donors:
- age up to 25 year
- healthy
- voluntary participation
- Exclusion Criteria:
- cancellation of the treatment
- no wish to participate any longer
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2017
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03237117
Start Date
January 1 2010
End Date
December 31 2017
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Granada
Granada, Spain, 18016